company background image
A365270 logo

curacleltd KOSDAQ:A365270 Stock Report

Last Price

₩5.63k

Market Cap

₩81.3b

7D

-3.6%

1Y

-36.4%

Updated

04 Dec, 2024

Data

Company Financials

A365270 Stock Overview

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels. More details

A365270 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

curacle co.,ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for curacleltd
Historical stock prices
Current Share Price₩5,630.00
52 Week High₩21,350.00
52 Week Low₩4,900.00
Beta1.51
11 Month Change-12.44%
3 Month Change0.36%
1 Year Change-36.38%
33 Year Change-75.47%
5 Year Changen/a
Change since IPO-81.63%

Recent News & Updates

Is curacleltd (KOSDAQ:365270) Using Too Much Debt?

Nov 01
Is curacleltd (KOSDAQ:365270) Using Too Much Debt?

curacleltd (KOSDAQ:365270) Has Debt But No Earnings; Should You Worry?

Jun 26
curacleltd (KOSDAQ:365270) Has Debt But No Earnings; Should You Worry?

Is Curacle (KOSDAQ:365270) Using Too Much Debt?

Feb 27
Is Curacle (KOSDAQ:365270) Using Too Much Debt?

Recent updates

Is curacleltd (KOSDAQ:365270) Using Too Much Debt?

Nov 01
Is curacleltd (KOSDAQ:365270) Using Too Much Debt?

curacleltd (KOSDAQ:365270) Has Debt But No Earnings; Should You Worry?

Jun 26
curacleltd (KOSDAQ:365270) Has Debt But No Earnings; Should You Worry?

Is Curacle (KOSDAQ:365270) Using Too Much Debt?

Feb 27
Is Curacle (KOSDAQ:365270) Using Too Much Debt?

Shareholder Returns

A365270KR BiotechsKR Market
7D-3.6%5.5%-1.0%
1Y-36.4%27.9%-2.6%

Return vs Industry: A365270 underperformed the KR Biotechs industry which returned 27.9% over the past year.

Return vs Market: A365270 underperformed the KR Market which returned -2.6% over the past year.

Price Volatility

Is A365270's price volatile compared to industry and market?
A365270 volatility
A365270 Average Weekly Movement8.4%
Biotechs Industry Average Movement8.2%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.7%
10% least volatile stocks in KR Market2.8%

Stable Share Price: A365270 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A365270's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016n/aJaehyeon Yoocuracle.com

Curacle Co., Ltd., a bio-venture business, engages in the research and development of drugs for diseases caused by aging process and damage to blood vessels. Its products cover age-related vascular diseases, intractable metabolic diseases, and cancer targeting/immunotherapy. The company’s products in pipeline include CU06, which covers treatment and medical indications, such as diabetic macular edema/retinopathy, acute respiratory distress syndrome, myocardial infarction, stroke treatment, concomitantly used with immunotherapy, inflammatory bowel disease treatment, and hereditary angioedema; CU03, which is in Phase 2a clinical trial study for the treatment of age-related macular degeneration; and CU01, a diabetic nephropathy medicine that completed Phase 2a clinical trial.

curacle co.,ltd. Fundamentals Summary

How do curacleltd's earnings and revenue compare to its market cap?
A365270 fundamental statistics
Market cap₩81.30b
Earnings (TTM)-₩16.49b
Revenue (TTM)₩1.77b

44.1x

P/S Ratio

-4.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A365270 income statement (TTM)
Revenue₩1.77b
Cost of Revenue₩15.26m
Gross Profit₩1.76b
Other Expenses₩18.25b
Earnings-₩16.49b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.19k
Gross Margin99.14%
Net Profit Margin-930.48%
Debt/Equity Ratio62.2%

How did A365270 perform over the long term?

See historical performance and comparison